|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/22 | |
| A61K 9/52 |
| (11) | Number of the document | 2552423 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11763349.5 |
| Date of filing the European patent application | 2011-03-30 | |
| (97) | Date of publication of the European application | 2013-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2017-07-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/030444 |
| Date | 2011-03-30 |
| (87) | Number | WO 2011/123497 |
| Date | 2011-10-06 |
| (30) | Number | Date | Country code |
| 282787 P | 2010-03-31 | US |
| (72) |
CHANG, Rong-Kun, US
VIEIRA, Michael, L., US
LIANG, Likan, US
BHATT, Padmanabh, P., US
HUANG, Austin, B., US
PATEL, Sachin, V., US
|
| (73) |
Supernus Pharmaceuticals, Inc.,
1550 East Gude Drive, Rockville, MD 20850,
US
|
| (54) | STABILIZED FORMULATIONS OF CNS COMPOUNDS |
| STABILIZED FORMULATIONS OF CNS COMPOUNDS |